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ABSTRACT
Background An important but often insufficient aspect 
of care in people with inflammatory arthritis (IA) is 
empowering patients to acquire a good understanding of 
their disease and building their ability to deal effectively 
with the practical, physical and psychological impacts of 
it. Self- management skills can be helpful in this regard.
Objectives To develop recommendations for the 
implementation of self- management strategies in IA.
Methods A multidisciplinary taskforce of 18 
members from 11 European countries was convened. 
A systematic review and other supportive information 
(survey of healthcare professionals (HCPs) and 
patient organisations) were used to formulate the 
recommendations.
Results Three overarching principles and nine 
recommendations were formulated. These focused on 
empowering patients to become active partners of the 
team and to take a more proactive role. The importance 
of patient education and key self- management 
interventions such as problem solving, goal setting and 
cognitive behavioural therapy were highlighted. Role 
of patient organisations and HCPs in promoting and 
signposting patients to available resources has been 
highlighted through the promotion of physical activity, 
lifestyle advice, support with mental health aspects and 
ability to remain at work. Digital healthcare is essential 
in supporting and optimising self- management and 
the HCPs need to be aware of available resources to 
signpost patients.
Conclusion These recommendations support the 
inclusion of self- management advice and resources in 
the routine management of people with IA and aim 
to empower and support patients and encourage a 
more holistic, patient- centred approach to care which 
could result in improved patient experience of care and 
outcomes.
INTRODUCTION
In people living with inflammatory arthritis (IA), 
as well as other rheumatic and musculoskel-
etal diseases (RMDs) and chronic conditions, an 
important aspect of care is the ability to understand 
the disease and deal with the practical, physical 
and psychological impacts that come along with 
it.1 2 This extends beyond drug therapy and places 
emphasis on the ability to self- manage as an essen-
tial component of care.3 Comorbidities including 
cardiovascular disease and common mental health 
conditions represent important, yet often poorly 
addressed aspects of IA despite their impact on 
disease outcomes.4 5 Addressing physical as well 
as psychological comorbidities is therefore crucial 
and more likely to be achieved if more holistic 
approaches to patient care are adopted, including, 
Key messages
What is already known on this subject?
 ► The ability to self- manage in inflammatory 
arthritis (IA) represents an essential component 
of care that goes beyond drug therapy and 
which supports the patient in managing the 
practical, physical and psychological impacts of 
disease.
 ► Self- management is a multicomponent complex 
intervention that represents an unmet need in 
the care of people with IA.
What does this study add?
 ► These recommendations, based on evidence and 
expert opinion, confirm the beneficial effects 
of different components of self- management 
and provide guidance on embedding self- 
management interventions into the routine 
clinical care of people with IA.
 ► This work highlights the value of patient 
organisations in providing support and 
structured guidance for people with IA and 
the need to demonstrate and document the 
effectiveness of specific self- management 
interventions.
How might this impact on clinical practice?
 ► Adherence to these recommendations will 
lead to improved patient care and outcomes 
in people living with IA and will encourage a 
more active patient role in the management of 
disease.
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for example, signposting, where appropriate, to other members 
of the multidisciplinary team (MDT).6 These members include, 
aside from rheumatologists, nurses, physiotherapists, occupa-
tional therapists, podiatrists, psychologists, nutritionists and any 
other healthcare professionals (HCPs) involved in the care of 
patients with IA.2 All these important aspects of disease which 
can place a high burden on the individual and their imme-
diate family necessitate the incorporation of supported self- 
management in the routine clinical care of people living with 
IA. For self- management to be effective however, it is imperative 
that HCPs (for the purposes of this work, reference to HCPs 
includes rheumatologists as well as allied health professionals) 
are given adequate guidance and professional training. This 
has a significant positive impact on their engagement in clinical 
self- management support and patient centredness, as well as on 
their overall confidence to support self- management.7 Patient 
organisations also play a role in the provision of supported 
self- management resources. Acknowledging all these important 
aspects of care, a taskforce supported by the European Alliance 
of Associations for Rheumatology (EULAR) was convened to 
embed recommendations alongside the standard medical care 
of IA that encourage supported patient self- management and 
concordance with treatment.
The overarching aim of the taskforce was to formulate recom-
mendations for the implementation of self- management strate-
gies in patients with IA, including but not limited to rheumatoid 
arthritis, psoriatic arthritis and axial spondyloarthritis. The 
target audience was HCPs including all members of the MDT 
and patients. There were three key objectives: (1) to develop 
EULAR recommendations for the implementation of effective 
self- management strategies facilitated by HCPs in IA concur-
rently with and complimentary to the delivery of standard 
medical care, (2) to enable all members of the rheumatology 
MDT to be able to provide and signpost a continuous and appro-
priate measure of support to enable better self- management of 
patient with IA and (3) to improve the patient’s ‘journey’ and 
experience during their care, disease outcomes and quality of 
life.
METHODS
The 2014 updated EULAR standardised operating proce-
dures were followed throughout the execution of this 
work.8 Following approval by the EULAR Executive 
Committee, the convenors (AB, EN) and methodolo-
gist (LC) led a taskforce of 18 members from across 11 
European countries. Taskforce members came with a 
background and expertise in rheumatology, nursing, occu-
pational therapy, psychology, self- management, exercise 
physiology and physiotherapy. The taskforce also included 
patient representatives with lived experience of IA from 
People with Arthritis/Rheumatism across Europe. Expert 
discussions took place primarily through two taskforce 
meetings, the first, face- to- face and the second, via a 
virtual online platform.
In preparation for the first meeting, an initial scoping 
review and a survey (available on request) were undertaken 
to explore, respectively, effective interventions in IA and 
self- management resources in RMDs across Europe. During 
the first meeting, the scope of this work, definitions for 
self- management and overarching principles (OAPs) were 
discussed. Furthermore, unmet need and key clinically rele-
vant questions were identified in relation to self- management 
in IA and sources of best practice examples explored.
In preparation for the second meeting and, as guided 
by the first meeting, clinical questions were converted by 
the steering group (AB, EN, LC, AM, EJFS) into epidemi-
ological questions that were addressed through systematic 
literature review (SLR) (under submission) undertaken 
by the taskforce fellows (AM, EJFS). The aim of the SLR 
was to identify the best evidence for the implementation of 
self- management interventions in IA and to describe indi-
vidual components and effects. The review was conducted 
according to the Cochrane Handbook9 and reported in 
accordance with the Preferred Reporting Items for System-
atic Reviews and Meta- Analyses guidelines.10 Patient organi-
sations affiliated with EULAR and HCPs across Europe were 
also approached via direct email communication requesting 
information and experience/feedback on examples of self- 
management resources in IA, to supplement the information 
retrieved from the SLR.
At the second meeting, the taskforce members formulated 
the OAPs and recommendations based on evidence from 
the SLR, survey, email communication with patient organ-
isations/HCPs and best practice examples, guided by their 
expert opinion and through a process of discussion and 
voting. Consensus was accepted in the first round if >75% of 
the members voted in favour of keeping it in. In the second 
and third rounds, after refinements, the level of agreement 
(LoA) was voted on a 0 to 10 scale (0=‘do not agree at all’ to 
10=‘fully agree’) anonymously. The second round was voted 
through Zoom polls during the second meeting and the third 
round through SurveyMonkey, afterwards. The mean and SD 
of the LoA was presented along with the percentage of task-
force members with an agreement ≥8. An indication of the 
level of evidence (LoE) based on the evidence retrieved from 
the SLR was discussed for each of the formulated recommen-
dations, to facilitate discussions. At the meeting, the LoE 
and strength of recommendation were assigned for each of 
the final drafted recommendations using the standards of the 
Oxford Centre for Evidence Based Medicine.11
Finally, a research agenda was formulated based on discussions 
around identified unmet need and gaps in evidence.
RESULTS
The taskforce discussed existing definitions for self- 
management and reached consensus on three OAPs and 
nine recommendations (table 1), guided by the results of the 
SLR, the surveys to patient organisations and HCPs relating 
to self- management resources, across EULAR countries 
(online supplemental file) and best practice examples (can 
be provided on request). In total, 12 patient organisations 
were approached of which 9 responded, representing eight 
different countries. A total of 13 HCPs were approached and 
100% replied from 13 different countries.
Definition
The definition and concept of self- management varies 
widely in the published literature and the context in which 
it is used.12 The taskforce aligned mostly with the well- 
established definition of self- management provided by 
Barlow et al13 whereby self- management is defined as ‘the 
ability of the individual to manage symptoms, treatment, 
lifestyle changes and psychosocial and cultural consequences 
of health conditions’. In this definition, two major compo-
nents were highlighted: (1) self- management is aimed at 
achieving independence and (2) ideally, self- management 
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should be supported by others, for example, HCPs, patient 
organisations and family. The taskforce proposed to empha-
sise the important contribution that patient organisations 
can make in supporting self- management for the purpose of 
this work and any future reference on the topic, something 
that has been largely overlooked and left out of most defi-
nitions to date.
Overarching principles
The taskforce identified key themes considered to apply across 
all recommendations, formulated and agreed as three OAPs.
1. Self- management implies taking an active role in learning 
about one’s condition and in the shared decision- making 
process about one’s health and care pathway.
Driven by the self- management definition above, it is impor-
tant that patients take an active role in understanding their 
condition and engage in acquiring self- management skills 
and coping strategies, as well as in shared decision- making, 
as part of their care. Effective supported self- management 
encompasses the ability to monitor one’s condition and to 
put into action the cognitive, behavioural and emotion-
al responses necessary to maintain a satisfactory quality of 
life.14–17 This way, a dynamic and continuous process of self- 
regulation is established. The importance of targeting and 
educating HCPs on self- management strategies and available 
resources, to ensure their ability to provide optimal support 
to patients, has been strongly emphasised.
2. Self- efficacy (personal confidence to carry out an activity 
with the aim of achieving a desired outcome) has a positive 
benefit on various aspects of living with IA.
Good self- efficacy and coping skills benefit and reduce 
health and financial burden to the individual as well as the 
health service, benefitting society overall.18 19 Self- efficacy, 
supported by the existing literature, implies a process as well 
as an outcome20 since it is also an important outcome of self- 
management interventions.1
3. Patient organisations often provide valuable self- management 
resources and collaboration between HCPs and patient or-
ganisations may therefore benefit patients.
There are numbers of best practice examples which in-
clude self- management resources in Europe, with impor-
tant benefits for patients. Aside from practical advice 
and physical support, patient organisations can provide 
support with mental health issues, self- isolation and 
loneliness,21 which commonly feature in patients with 
IA. HCPs should take responsibility for addressing these 
issues in people living with IA and signpost to patient 
organisations. The taskforce acknowledges that variation 
exists both in healthcare delivery and the resources that 
patient organisations can offer. In some countries such 
as the UK, patient organisations invite HCPs to become 
medical advisors to the organisation and also provide 
free membership to all HCPs. Their medical advisors ac-
tively contribute educational articles for their magazines 
and to patient- related campaigns, educational activities 








Mean (SD) % with score ≥8
OAPs   
A. Self- management implies taking an active role in learning about one’s condition and in the shared decision- 
making process about one’s health and care pathway.
n.a n.a 9.5 (0.6) 100
B. Self- efficacy (personal confidence to carry out an activity with the aim of achieving a desired outcome) has a 
positive effect on various aspects of living with IA.
n.a n.a 9.6 (0.7) 100
C. Patient organisations often provide valuable self- management resources and collaboration between healthcare 
professionals (HCPs) and patient organisations will therefore benefit patients.
n.a n.a 9.4 (1.0) 88
Recommendations   
R1. HCPs should encourage patients to become active partners of the team and make them aware of HCPs and 
patient organisations involved in all aspects of the care pathway.
5 D 9.5 (1.1) 87
R2. Patient education should be the start point and underpin all self- management interventions. 1A A 9.5 (0.8) 93
R3. Self- management interventions that include problem solving and goal setting and, where relevant to the 
individual and available, cognitive behavioural therapy should be incorporated into routine clinical practice to 
support patients.
1A A 9.1 (1.4) 93
R4. HCPs should actively promote physical activity at diagnosis and throughout the disease course. 1A A 9.9 (0.3) 100
R5. Lifestyle advice based on evidence should be given to better manage common comorbidity and patients should 
be guided and encouraged by their healthcare team to adopt healthy behaviours.
5 D 9.6 (0.6) 100
R6. Better emotional well- being leads to better self- management; therefore, mental health needs to be assessed 
periodically and appropriate intervention should be made if necessary.
5 D 9.4 (1.3) 93
R7. HCPs should invite discussion with patients about work and signpost to sources of help where appropriate or 
where needed.
5 D 9.6 (0.5) 100
R8. Digital healthcare can help patients to self- manage and should be considered for inclusion in supported self- 
management where appropriate and available.
1B A 9.3 (1.0) 93
R9. HCPs should make themselves aware of available resources to signpost patients to, as part of optimising and 
supporting self- management.
5 D 8.7 (1.2) 100
EULAR, European Alliance of Associations for Rheumatology; LoE, level of evidence (1–5; 1 indicating evidence from high- quality randomised clinical trial (RCT) data and 5 
indicating evidence from expert opinion without explicit critical appraisal or based on physiology, bench research or ‘first principles’)11; n.a, not applicable; SoR, strength of 
recommendation (A–D; A indicating consistent level 1 studies (RCTs) and D indicating level 5 evidence or troublingly inconsistent or inconclusive studies of any level).
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and others. There is a close relationship that encourages 
cross- talk and collaboration that can be of huge benefit 
to patients.
Recommendations
R1. HCPs should encourage patients to become active partners of 
the team and make them aware of HCPs and patient organisations 
involved in all aspects of the care pathway
For patients to take a more active role in their health, it is 
important that they are introduced to all members of the MDT 
involved in all aspects of their disease. Patient organisations can 
provide an invaluable source of information and resources to 
support patients. Yet, there seems to be a general lack of aware-
ness of the self- management resources (and potential value) 
provided by many patient organisations (eg, in terms of patient 
education/disease knowledge, advocacy and other resources) and 
hence referral to these resources by HCPs. Some patients already 
engage in self- management and reach out to patient organisa-
tions for support. We acknowledge that patient organisations 
or at least well- developed patient organisations are not always 
available in many parts of Europe. Where available, patients 
should be signposted to relevant patient organisations in parallel 
with all other care and treatment they may be receiving.22 23 
Where not available, we recommend using existing sources of 
information from the websites of other patient organisations and 
generally from trusted internet information sites, books and any 
other educational material that may be easily accessible online 
or via other routes.
R2. Patient education should be the start point and underpin all self-
management interventions
Specific interactive education was among the most studied inter-
vention across 19 randomised clinical trials (RCTs) based on 
the findings of the systematic review informing this taskforce 
(under submission). Self- management is considered a complex 
intervention as it contains many interacting techniques, thus 
making it difficult to identify the most effective components.18 
Patient education is considered crucial, but not sufficient, in 
the context of self- management and is included in a majority of 
interventions.24–30 Patient education has been shown to improve 
treatment adherence, based on clinical trial evidence, although 
patient sample and follow- up time were both limited.26 The task-
force considers treatment adherence (and discussions addressing 
this) to be part of the patient education plan.31 Patient organisa-
tions reinforce the information and messaging about adherence 
and the impact of peer reinforcement around adherence is very 
powerful.
EULAR has produced recommendations for patient education 
for people with IA addressing when and by whom patient educa-
tion should be offered, as well as modes and methods of delivery, 
theoretical frameworks, outcomes and evaluation.32 We advo-
cate the use of these recommendations when it comes to patient 
education, recognising that patient education is an integral part 
of supported self- management for people with IA throughout 
the course of their disease.
R3. Self-management interventions that include problem solving 
and goal setting and, where relevant to the individual and available, 
cognitive behavioural therapy (CBT), should be incorporated into 
routine clinical practice to support patients
There are various self- management interventions. These include 
problem solving27 29 30 33–39 and goal setting,27 29 30 33 34 37 39 as well 
as cognitive behavioural therapy (CBT),28 33 35 37–41 supported 
by several SLRs and RCTs. The three interventions highlighted 
in this recommendation were therefore supported by strong 
evidence in their role in self- management. We advocate that they 
are promoted and provided where available and are relevant to 
patients, to enhance their ability to manage their disease confi-
dently.42 CBT is a psychosocial intervention, often delivered by 
psychologists/psychotherapists, but also by some nurse special-
ists who have done a course in CBT and this further highlights 
the important role of the MDT. Referral to CBT can be initiated 
by any HCP involved in the care of the patient, if any doubt, in 
liaison with an expert delivering the intervention.
R4. HCPs should actively promote physical activity at diagnosis and 
throughout the disease course
Ample evidence from the existing literature supports the use of 
physical activity in IA and demonstrates its beneficial effect on 
several outcomes.43–49 Existing EULAR recommendations on 
physical activity50 emphasise its importance in disease manage-
ment, based on proven effectiveness, feasibility and safety. Phys-
ical activity should thus form an integral part of standard patient 
care and be actively promoted and tailored to the individual’s 
circumstances, throughout their disease course. HCPs should be 
aware of the benefits of physical activity and advocate this as 
an important component of self- management. Any HCP should 
be able to promote the benefits of being physically active and 
take regular exercise and initiate a referral for physical therapy if 
deemed appropriate. If discussion is required with a physiother-
apist or other physical exercise expert regarding the need and 
type of physical activity appropriate for an individual, then HCPs 
should know whom to approach for this. While there is a consid-
erable amount of evidence for the beneficial effects of exercise, 
there is a general lack of emphasis on this aspect of care. Most 
interventions in regard to exercise relate to referral to a phys-
iotherapist. However, the taskforce emphasises the importance 
and potential of exercise programmes and information provided 
by patient organisations and other community programmes, for 
example, classes which might include physical activities such as 
aquarobics, swimming, dancing, yoga and pilates.51
R5. Lifestyle advice based on evidence should be given to better 
manage common comorbidity and patients should be guided and 
encouraged by their healthcare team to adopt healthy behaviours
A number of modifiable lifestyle factors in IA can affect 
outcome.52 For example, the negative effects of smoking53 as 
well as high body mass index54 impact on inflammation and 
disease activity are now well established, as is the increased 
risk of cardiovascular disease.55 Lifestyle approaches should 
complement medical treatments, as also supported by a EULAR 
taskforce dedicated to providing recommendations on specific 
lifestyle interventions for the management of RMDs (currently 
ongoing). This taskforce considers such interventions to be a 
core part of self- management and advocates that patients receive 
support to adopt healthy behaviours including guidance on 
what constitutes a healthy, balanced diet, the benefits of exercise 
and quitting smoking, among others. Where specialised input 
is needed, for example, on nutrition, the input from dieticians 
should be sought where possible, acknowledging that dieticians 
are not always ‘standard’ members of the MDT so external 
support might be required. Such interventions are expected 
to have a positive impact on comorbidities and extra- articular 
manifestations, as well as the IA itself and should be accompa-
nied by relevant investigations such as lipid profile testing, blood 
pressure monitoring and sleep hygiene.4 6 56 57 The addressing 
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of comorbidities and initiation of relevant investigations may 
be undertaken by primary care physicians, rheumatologists or 
other HCPs such as nurses, involved in the patient’s care and as 
part, for example, of an annual review clinic. Some centres have 
their own pro formas for screening of comorbidities or lifestyle 
factors, for example, smoking, and these can be helpful as part of 
the screening process and facilitate the process for any member 
of the MDT.
R6. Better emotional well-being leads to better self-management; 
therefore, mental health needs to be assessed periodically and 
appropriate intervention be made if necessary
Poor mental health leads to worse outcomes in IA.58–60 CBT and 
other psychosocial interventions43 61–64 should be offered where 
available and tailored according to individual needs. Addressing 
mental health issues can help mitigate self- isolation and feelings 
of loneliness and can result in better self- management.59 65 Exam-
ples of questionnaires that could be used to measure patients’ 
emotional well- being feasibly in routine clinical practice include 
the mental health component of the SF3666 and the Patient 
Health Questionnaire (PHQ-9).67 The taskforce acknowledges 
that many patient organisations provide forums for networking 
and peer support programmes which can improve emotional 
well- being. Furthermore, we acknowledge that patients requiring 
more specialist assessment and support for mental health issues 
should be signposted as necessary, for example, to psychology 
and/or psychiatry.
R7. HCPs should invite discussion with patients about work and 
signpost to sources of help where appropriate or where needed
EULAR’s current strategy states that ‘by 2023, EULAR’s activities 
and related advocacy will have increased participation in work 
by people with RMDs’.68 The greatest proportion of people 
with IA are of working age at the time of diagnosis and work 
represents a major contributor to financial independence, self- 
esteem, purpose in life and overall quality of life.2 69 70 There-
fore, it is crucial to the taskforce that HCPs address work- related 
aspects and signpost the patients to useful resources and support 
them to stay in work and maintain their independence.71 Occu-
pational therapists and occupational health experts can provide 
helpful advice and resources in relation to the workplace.
R8. Digital healthcare can help patients to self-manage and should 
be considered for inclusion in supported self-management, where 
appropriate and available
Electronic patient records and other digital resources such as 
mobile health apps are becoming increasingly available in health-
care delivery.72 Mobile health technologies in particular can 
support self- management and allow people to take a more active 
role in their health.72 73 Patient- reported outcome domains as 
deemed relevant and important by patients could also be consid-
ered with digital healthcare. EULAR recommendations provide 
guidance on important aspects that should be considered for the 
development, evaluation and implementation of existing and 
new apps.74 The taskforce recommends referring to EULAR 
guidance on the above.
R9. HCPs should make themselves aware of available resources to 
signpost patients to, as part of optimising and supporting self-
management
The taskforce highlighted the need for HCPs to be made aware 
of available resources for patients with IA, including those 
provided by patient organisations, to promote and support 
self- management interventions. At the same time, the taskforce 
recognised that just as there’s variation in healthcare resources, 
there is also variation in what patient organisations can offer.75
DISCUSSION
This EULAR taskforce has produced three OAPs relevant to nine 
agreed recommendations for the implementation of supported 
self- management strategies in patients with IA. OAPs and recom-
mendations were met with strong consensus among experts in 
the task force.
The concept of self- management to some may imply needing 
to deal alone with a chronic condition.76 Receiving adequate 
support from a variety of sources is crucial.77 A key role of HCPs 
is also to enable access to and to signpost to supported self- 
management resources. Many HCPs will need to make themselves 
aware of how to most effectively provide and signpost to these 
different resources. The taskforce highlighted the importance of 
honesty and building trust as important elements for establishing 
open communication between patients and HCPs.78–81 Adequate 
time should be given to patients, as well as family and carers 
to discuss concerns and management options.82 83 Forward 
planning should be based on goal setting and what matters to 
patients, as supported by the existing literature.27 29 30 33 34 37 39 
Furthermore, it was recognised that context, in other words, 
health system, culture or local resources, vary across settings and 
that nothing can be implemented without a clear familiarity and 
understanding of the local context. It is therefore important to 
understand and appreciate individual circumstances and social 
context when it comes to patient care, to maximise chances of 
implementing proposed care and supported self- management 
plans.84 85 For example, potential barriers to effective engage-
ment with self- management could include poor health literacy 
and cultural or personal barriers, for example, for the latter, 
language barriers and low education. These should be identified 
where possible to maximise the support given to patients and 
to enhance their overall participation in self- management strat-
egies. In some countries, patient organisations are particularly 
influential and with well- developed, active websites, support 
lines, educational material and some even with self- management 
programmes already established and made available to patients, 
families and carers. We encourage the use of social media such as 
Facebook, Twitter, websites and advertisements, for example, on 
national TV/radio to promote these resources.
Exploration of various definitions of self- management by 
the task force indicated that more holistic definitions of self- 
management reflecting the ‘individual’s ability to manage 
symptoms, treatment, physical and psychosocial consequences 
and lifestyle changes inherent in living with a chronic condi-
tion’ were more warmly received.3 The taskforce additionally 
highlighted the important contribution that patient organisa-
tions can make in supporting self- management, an aspect that 
has been largely left out of definitions to date. The latter is 
supported by additional sources of evidence informing this task 
force including direct communication with chief executives of 
patient organisations and best practice examples (available on 
request). However, the taskforce noted that the constitution of 
patient organisations varies considerably from large professional 
expert organisations led by paid chief executive officers and 
staff governed by boards of trustees to very small organisations 
which are primarily volunteer led. This means that the resources 
provided by patient organisations also vary.
Patient education has been identified as a crucial compo-
nent that should underpin all self- management interventions. 
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Effective patient education should be the responsibility of both 
the HCPs and the patients themselves. Patient education has 
been shown to improve treatment adherence,26 something that 
this taskforce recognises as an important part of patient educa-
tion. Furthermore, patient outcomes including effective disease 
knowledge, healthcare management and self- efficacy have been 
shown to improve with patient education.24–30
The vision of the taskforce is that patient–HCP commu-
nication, the setting of meaningful and achievable goals and 
shared decision- making are seen as core components of self- 
management. This aligns well with EULAR’s current quality- 
of- care strategy that by 2023, EULAR will deliver pre- eminent 
comprehensive quality of care frameworks for the management 
of people with RMDs. One of the main quality- of- care objectives 
is to provide a ‘package’ that will enable greater uptake of the 
advice given in the recommendations, in other words emphasis 
on implementation aspects.68 In this regard and in relation to the 
nine recommendations, the taskforce recognised the importance 
of:
1. Raising awareness and educating HCPs on self- management 
strategies and available resources, to ensure ability to provide 
optimal support to patients.
2. Efforts to increase awareness and strengthen collaborations 
between patients, patient organisations and HCPs.
3. Signposting patients to good evidence- based information, 
also provided by many patient organisations.
4. Patient education as a crucial component of self- management, 
while acknowledging that being educated around various as-
pects of the disease does not necessarily imply implementa-
tion of meaningful changes.
It was particularly highlighted that training of HCPs, for 
example, on CBT, can improve their skills to deliver interven-
tions and can be of great benefit to patients.28 33 35 37–41 The task-
force emphasised the need and importance of members of the 
MDT to be encouraged to work as a team towards implementa-
tion of the specific recommendations. Knowledge sharing should 
form a core part of these MDT meetings. Additionally, indi-
vidual needs and variation in national health systems, availability 
of local resources and patient organisation offerings should be 
considered as part of the implementation. Finally, it is important 
to keep in mind that for self- management to be effective, the 
mode of delivery of various interventions should be considered 
in the setting of disease and severity, individual social circum-
stances and available resources. Referral to occupational health, 
occupational therapy patient organisations for resources related 
to work issues and other support should be considered where 
indicated and available.
With the recognition of all the above, unmet need has been 
identified and a research agenda has been proposed (box 1) for 
future work on the subject. An important focus has been the value 
of patient organisations and information and other resources 
they can provide to support people with IA, as well as the need 
to demonstrate and document the effectiveness of specific self- 
management interventions. It is particularly challenging for 
patient organisations to demonstrate the value of what they do, 
however, this does not remove the need for them to make real 
effort to demonstrate the impact of their resources. The taskforce 
identified, as part of the educational agenda, that there is scope 
for using best practice self- management programme examples to 
encourage and support other less- developed patient organisa-
tions and healthcare systems to work towards developing similar 
patient resources. Furthermore, in current clinical practice there 
is a strong emphasis on achieving clinical markers that are of 
importance to HCPs, for example, lowering of disease activity, 
whereas this taskforce is advocating that more focus should be 
given to goals that are more meaningful to the patients in the 
context of their everyday lives. In this respect, we recommend 
raising awareness among HCPs of the importance of the biopsy-
chosocial determinants of health.
CONCLUSIONS
In conclusion, EULAR recommendations are now available for 
the implementation of self- management strategies in patients with 
IA. A dissemination strategy is currently underway to enhance 
the uptake of these recommendations, through national organi-
sations, patient organisations and educational programmes.
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Box 1 Research agenda
Self- management in inflammatory arthritis (IA)—identified 
unmet need and suggested focus for future research.
1. To demonstrate the effectiveness of specific self- management 
interventions in IA and their impact on disease activity.
2. To study specific patient- reported outcome domains 
potentially affected by self- management including pain, 
fatigue, sleep, emotional and physical well- being, disability, 
quality of life and self- efficacy and explore a core outcome 
set.
3. To elucidate the cost- effectiveness of specific self- 
management interventions and programmes delivered.
4. To study the role of patient organisations and explore the 
impact of these organisations and the resources and support 
they provide for people with IA.
5. To investigate the impact of remotely delivered self- 
management interventions compared with face- to- face 
interventions.
6. To explore how the European Alliance of Associations for 
Rheumatology community could implement strategies to 
support and enable less established patient organisations to 
adapt best practice examples to suit their local circumstances.
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